Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23348)

Formulation Name
Lapatinib Ditosylate eq 250mg base tablet
Company
Novartis
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Certolake sunset yellow E00351 61817 Colorant
Hypromellose E00634 Not Available Coating agent
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 400 E00653 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80 E00665 Not Available Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent